What amount sold does Braasch Biotech LLC report in Form D filings?

The latest linked filings report $0 sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Braasch Biotech LLC's most recent SEC filing?

Braasch Biotech LLC's most recent Form D filing was on 2012-04-09.

What type of securities does Braasch Biotech LLC offer?

Braasch Biotech LLC's SEC Form D filings indicate equity, debt offerings.

Braasch Biotech LLC

CIK: 0001546815·Biotechnology·GARRETSON, SD·Limited Liability Company·Founded 2008

Reported Sold

Total Filings

Identified Offerings

Last Filed

Apr 9, 2012

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Apr 9, 2012Form D — New notice

Reported sold: $0 · Target: Indefinite

Rule 505·0 investors·Rule 506

Fundraising Profile

Exemptions

Rule 505

Investors in latest filing

Revenue Range

No Revenues

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Jeralyn Kay Haffer

Related Person

Appears on 1 filing

Keith Neil Haffer

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Apr 9, 2012	New	Indefinite	$0	0

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Lion River Fund LLC

Biotechnology

Offering target: $25,000,000

Filed Aug 31, 2026